trazodone has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After experiencing a major Covid-19-related personal trauma, patients showed clinical worsening which required dosage adjustment (20 mg/day vortioxetine; 600 mg/day trazodone, and 200 mg/day sertraline) and, for some of them, hospitalisation." | 1.72 | Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma. ( Amici, E; De Filippis, S; Di Giovanni, A; Giovanetti, V; Kotzalidis, GD; Lombardozzi, G; Matrone, M; Perrini, F; Trovini, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Filippis, S | 1 |
| Lombardozzi, G | 1 |
| Matrone, M | 1 |
| Amici, E | 1 |
| Trovini, G | 1 |
| Perrini, F | 1 |
| Di Giovanni, A | 1 |
| Giovanetti, V | 1 |
| Kotzalidis, GD | 2 |
| Mazza, M | 1 |
| Caroppo, E | 1 |
| Marano, G | 1 |
| Avallone, C | 1 |
| Camardese, G | 1 |
| Janiri, D | 1 |
| Moccia, L | 1 |
| Simonetti, A | 1 |
| Janiri, L | 1 |
| Sani, G | 1 |
| Jones, A | 1 |
| Goodarzi, Z | 1 |
| Lee, J | 1 |
| Norman, R | 1 |
| Wong, E | 1 |
| Dasgupta, M | 1 |
| Liu, B | 1 |
| Watt, J | 1 |
| Coin, A | 1 |
| Noale, M | 1 |
| Gareri, P | 1 |
| Trevisan, C | 1 |
| Bellio, A | 1 |
| Fini, F | 1 |
| Abbatecola, AM | 1 |
| Del Signore, S | 1 |
| Malara, A | 1 |
| Mossello, E | 1 |
| Fumagalli, S | 1 |
| Volpato, S | 1 |
| Monzani, F | 1 |
| Bellelli, G | 1 |
| Zia, G | 1 |
| Incalzi, RA | 1 |
4 other studies available for trazodone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.
Topics: Adult; Antidepressive Agents; COVID-19; Depressive Disorder, Major; Double-Blind Method; Female; Hum | 2022 |
Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to COVID-19 Pandemic: A Case Series.
Topics: Cannabis; Communicable Disease Control; COVID-19; COVID-19 Drug Treatment; Female; Hallucinogens; Hu | 2022 |
Chemical and physical restraint use during acute care hospitalization of older adults: A retrospective cohort study and time series analysis.
Topics: Aged; Alberta; Benzodiazepines; COVID-19; Hospitalization; Humans; Pandemics; Restraint, Physical; R | 2022 |
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; COVID-19; Cross-Sectional Studies; Dementia; Female; | 2023 |